HIV, Equity, and Addiction Training (HEAT) Program
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 30
- Locations
- 2
- Primary Endpoint
- Percent of participants who have a follow-up healthcare visit
Study Overview
Brief Summary
This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.
Detailed Description
The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Receiving services at HIV clinics in Alabama
- •Reported opioid and/or stimulant misuse
- •18 years of age or older
Exclusion Criteria
- •Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months
- •Inability to engage in interviews independently without support (e.g., cognitive impairment)
- •Currently psychotic
- •Actively suicidal: presents with a suicide attempt or suicidal ideation
Arms & Interventions
Patients living with HIV and substance use
Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.
Intervention: Telemedicine (Other)
Patients living with HIV and substance use
Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.
Intervention: Standard of care (Other)
Outcomes
Primary Outcomes
Percent of participants who have a follow-up healthcare visit
Time Frame: 1 month, 2 months, 3 months
Follow up visit for care (either telemedicine or in person)
Secondary Outcomes
No secondary outcomes reported
Investigators
Ellen Eaton
Associate Professor
University of Alabama at Birmingham
